Penta-O-Galloyl-β-D-Glucose in Pistacia integerrima Targets AMPK-ULK1 and ERK/STAT3 Signaling Axes to Induce ROS-Independent Autophagic Cell Death in Human Lung Cancer Cells
Graphical Abstract.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Frontiers in Pharmacology - 13(2022) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Acharya Balkrishna [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
AMPK activator |
|---|
| doi: |
10.3389/fphar.2022.889335 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ041162544 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ041162544 | ||
| 003 | DE-627 | ||
| 005 | 20230502144232.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fphar.2022.889335 |2 doi | |
| 035 | |a (DE-627)DOAJ041162544 | ||
| 035 | |a (DE-599)DOAJf850b12e37c6498b92d4ef19fc157603 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RM1-950 | |
| 100 | 0 | |a Acharya Balkrishna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Penta-O-Galloyl-β-D-Glucose in Pistacia integerrima Targets AMPK-ULK1 and ERK/STAT3 Signaling Axes to Induce ROS-Independent Autophagic Cell Death in Human Lung Cancer Cells |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Graphical Abstract | ||
| 650 | 4 | |a penta-O-galloyl-β-D-glucose | |
| 650 | 4 | |a autophagic cell death | |
| 650 | 4 | |a UPLC/Q-TOF-MS | |
| 650 | 4 | |a STAT3 inhibitor | |
| 650 | 4 | |a AMPK activator | |
| 650 | 4 | |a natural molecules | |
| 653 | 0 | |a Therapeutics. Pharmacology | |
| 700 | 0 | |a Acharya Balkrishna |e verfasserin |4 aut | |
| 700 | 0 | |a Acharya Balkrishna |e verfasserin |4 aut | |
| 700 | 0 | |a Vallabh Prakash Mulay |e verfasserin |4 aut | |
| 700 | 0 | |a Sudeep Verma |e verfasserin |4 aut | |
| 700 | 0 | |a Jyotish Srivastava |e verfasserin |4 aut | |
| 700 | 0 | |a Savita Lochab |e verfasserin |4 aut | |
| 700 | 0 | |a Anurag Varshney |e verfasserin |4 aut | |
| 700 | 0 | |a Anurag Varshney |e verfasserin |4 aut | |
| 700 | 0 | |a Anurag Varshney |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Pharmacology |d Frontiers Media S.A., 2010 |g 13(2022) |w (DE-627)DOAJ000099732 |x 16639812 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fphar.2022.889335 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/f850b12e37c6498b92d4ef19fc157603 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fphar.2022.889335/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1663-9812 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 | ||